Skip to main content

Table 1 Subject Characteristics at the Entry Visit

From: Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy

Characteristic Value
Age, years, median (range) 41.5 (23–64)
Male, n (%) 39 (78%)
Race, n (%) White, not Hispanic 33 (66%)
   Black, not Hispanic 10 (20%)
   Hispanic 4 (8%)
   Other 3 (6%)
Years of education, median (range) 13 (9–18)
NPZ4, mean (standard deviation) -0.46 (0.72)
Current antiretroviral use, n (%) 33 (66%)
   ARVs with good CNS penetration, median (range) 3 (0–4)
   Two or more ARVs with good CNS penetration, n (%) 28 (85%)
Peripheral blood CD4+ T cells/ul, median (range) 467 (3–1016)
Plasma HIV RNA (49 subjects)  
   Detectable n (%) 29 (58%)
   RNA log copies/ml in those with detectable plasma HIV RNA, median (range) 3.50 (1.82–5.48)
CSF WBC  
   WBC > 5/ul, n (%) 15 (30%)
   CSF WBC in those with > 5/ul, median, (range) 13 (7–51)
CSF HIV RNA  
   Detectable, n (%) 17 (34%)
   CSF HIV RNA log copies/ml in those with detectable CSF HIV RNA, median (range) 2.92 (1.71–4.08)
  1. HIV, human immunodeficiency virus
  2. NPZ4, normalized score on four neuropsychological tests
  3. RNA, ribonucleic acid
  4. CSF, cerebrospinal fluid
  5. WBC, white blood cell
  6. Detectable, > 50 copies/ml
  7. ARV, antiretroviral agent